Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
Boundless boldly goes public with $100M IPO
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024.
James Waldron
Mar 28, 2024 7:10am
Boundless Bio eyes $88M offering as spring IPO market blooms
Mar 21, 2024 8:50am
J&J-allied bio files IPO to take fight to BMS, Roche and more
Mar 18, 2024 7:15am
Acelyrin rebounds with psoriatic arthritis victory
Mar 11, 2024 10:59am
Boundless Bio bumps IPO market back to life
Mar 6, 2024 5:20pm
Metagenomi, Telomir offer double test case for preclinical IPOs
Feb 9, 2024 7:00am